L-Norvaline t-butyl ester hydrochloride, 95.0%, 2.5g

5-phenylthiophene-2-carboxylic acid, 95.0%, 5g

2-Chloro-4-(trifluoromethyl)benzoic acid, 95.0%, 5g

Methyl 4-amino-3-iodo-5-methoxybenzoate, 95.0%, 1g

1,3-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 25g

Éster etílico del ácido cloroacético, >=98%, para síntesis, 1 L, envase de vidrio

N-((4,6-dimethoxypyrimidin-2-yl)carbamoyl)-3-(trifluoromethyl)pyridine-2-sulfonamide, 98%, 1g

2-Methylbiphenyl>95.0%(GC)1g

2-Amino-5-fluorobenzamide, 95.0%, 5g

2,2-Diphenylethanol, 99.0%, 1g

1-(4-Methylphenyl)ethanol, 96.0%, 5g

2-Acetylfluorene>98.0%(GC)100g

(3-(tert-Butoxy)-2',6'-diisopropyl-6-methoxy-[1,1'-biphenyl]-2-yl)dicyclohexylphosphane, 98%, 250mg